Advertisement
Screener

IRADIMED CORPORATION (IRMD) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price

3.1 / 5 stars · 74/120 Roast Me

IRADIMED CORPORATION Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price

IRADIMED CORPORATION (IRMD) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $6.42 per share for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-10.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2016-03-10

  • IRADIMED CORPORATION share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2015 was $6.42.
  • IRADIMED CORPORATION share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2014 was $0.00.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month
2015-12-31$6.42
10-K · filed 2016-03-10
2014-12-31$0.00
10-K · filed 2015-03-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ARTIVION, INC. (AORT)United States$1.123B-345.09
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02